chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 6 patients received the expired doses on 07Jan2022 and 12Jan2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (6 patients received the expired doses on 07Jan2022 and 12Jan2022) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    In January 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (6 patients received the expired doses on 07Jan2022 and 12Jan2022). In January 2022, EXPIRED PRODUCT ADMINISTERED (6 patients received the expired doses on 07Jan2022 and 12Jan2022) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Drug details were reported.  No Treatment information was provided.   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069H21A) for COVID-19 vaccination.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU) for an unknown indication.    No Medical History information was reported.   On 21-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-455441 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: a patient received 0.5ml instead of 0.25ml as their booster dose of the Moderna Covid-19 Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (a patient received 0.5ml instead of 0.25ml as their booster dose of the Moderna Covid-19 Vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (a patient received 0.5ml instead of 0.25ml as their booster dose of the Moderna Covid-19 Vaccine). At the time of the report, ACCIDENTAL OVERDOSE (a patient received 0.5ml instead of 0.25ml as their booster dose of the Moderna Covid-19 Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration, Off label use
Clinical narrative: patient return for the second dose past the 28 days recommended so patient was advice to start the series over; patient got 3 full Moderna vaccines; Off label use; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient return for the second dose past the 28 days recommended so patient was advice to start the series over), EXTRA DOSE ADMINISTERED (patient got 3 full Moderna vaccines) and OFF LABEL USE (Off label use) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A, 002B21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient return for the second dose past the 28 days recommended so patient was advice to start the series over), EXTRA DOSE ADMINISTERED (patient got 3 full Moderna vaccines) and OFF LABEL USE (Off label use). On 23-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient return for the second dose past the 28 days recommended so patient was advice to start the series over), EXTRA DOSE ADMINISTERED (patient got 3 full Moderna vaccines) and OFF LABEL USE (Off label use) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment medication information was not provided.   This case was linked to MOD-2022-455788 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose on 18MAR2021 and second dose on 28APR2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 18MAR2021 and second dose on 28APR2021) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 18MAR2021 and second dose on 28APR2021). On 28-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 18MAR2021 and second dose on 28APR2021) had resolved.            She is severly immunocompromised with rheumatoid arthritis and is taking medications for the condition. No treatment information were reporter by the reporter   This case was linked to MOD-2022-455422 (Patient Link).
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product administered to patient of inappropriate age
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year old received Moderna vaccine as Booster) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered the Moderna COVID-19 vaccine by mistake because he was supposed to receive Pfizer as booster dose) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination. Previously administered products included for COVID-19 vaccination: Pfizer (1st dose) on 18-May-2021 and Pfizer (2nd dose) on 08-Jun-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included Acne. Concomitant products included TRETINOIN (RETIN A) for Acne. On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year old received Moderna vaccine as Booster). 11-Jan-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered the Moderna COVID-19 vaccine by mistake because he was supposed to receive Pfizer as booster dose). On 11-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 14 year old received Moderna vaccine as Booster) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered the Moderna COVID-19 vaccine by mistake because he was supposed to receive Pfizer as booster dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Herpes zoster, Rash
Clinical narrative: initially started as a burning sensation on the left side of his body; rashes starting to come out; shingles really bad; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles really bad), BURNING SENSATION (initially started as a burning sensation on the left side of his body) and RASH (rashes starting to come out) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2022, the patient experienced HERPES ZOSTER (shingles really bad) and RASH (rashes starting to come out). On an unknown date, the patient experienced BURNING SENSATION (initially started as a burning sensation on the left side of his body). At the time of the report, HERPES ZOSTER (shingles really bad), BURNING SENSATION (initially started as a burning sensation on the left side of his body) and RASH (rashes starting to come out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Patient was prescribed with an antiviral. Reportedly, Patient went to an immediate care clinic. Additionally, It was reported that patients second dose of vaccine was schedule on 03-Feb-2022.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Insomnia
Clinical narrative: Slept a little; Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Slept a little) and FATIGUE (Fatigued) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced INSOMNIA (Slept a little) and FATIGUE (Fatigued). At the time of the report, INSOMNIA (Slept a little) and FATIGUE (Fatigued) had resolved.            No concomitant medication were reported. No treatment medication were reported.   This case was linked to MOD-2022-455602, MOD-2022-455604, MOD-2022-455785 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Headache, Hypoacusis, Malaise
Clinical narrative: I'm still not doing very well; Headaches; I'm having problems with my hearing; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (I'm having problems with my hearing), MALAISE (I'm still not doing very well) and HEADACHE (Headaches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2022, the patient experienced HYPOACUSIS (I'm having problems with my hearing) and HEADACHE (Headaches). On an unknown date, the patient experienced MALAISE (I'm still not doing very well). At the time of the report, HYPOACUSIS (I'm having problems with my hearing), MALAISE (I'm still not doing very well) and HEADACHE (Headaches) had not resolved.            Concomitant medications were not reported. Treatment details were not reported.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: Felt sluggish; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (Felt sluggish) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Nauseated (sometimes feeling nauseated), Dizziness (occasional) and Muscle pain.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 16-Aug-2021, the patient experienced SLUGGISHNESS (Felt sluggish). At the time of the report, SLUGGISHNESS (Felt sluggish) outcome was unknown.            No concomitant medication information was provided. No treatment medication information was provided.  Patient received third full dose of Moderna vaccine. Patient considered himself immunocompromised although he reported he has not been classified as being immunocompromised by his doctor.   This case was linked to MOD-2022-455587, MOD-2022-455604, MOD-2022-455785 (Patient Link).   Reporter did not allow further contact
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Vaccination site pain
Clinical narrative: Left arm sore/like a muscle contraction; This booster dose was actually his fourth dose/Extra dose administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm sore/like a muscle contraction) and EXTRA DOSE ADMINISTERED (This booster dose was actually his fourth dose/Extra dose administered) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Nauseated, Dizziness and Muscle pain.    On 13-Jan-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 13-Jan-2022, the patient experienced EXTRA DOSE ADMINISTERED (This booster dose was actually his fourth dose/Extra dose administered). On 14-Jan-2022, the patient experienced VACCINATION SITE PAIN (Left arm sore/like a muscle contraction). On 13-Jan-2022, EXTRA DOSE ADMINISTERED (This booster dose was actually his fourth dose/Extra dose administered) had resolved. At the time of the report, VACCINATION SITE PAIN (Left arm sore/like a muscle contraction) outcome was unknown.            No concomitant medications were provided.  The reporter stated that the vaccination site thought he was receiving his 3rd shot (booster dose) because the vaccination card the he gave to the facility did not show that he had already received a 3rd full dose on 16 August 2021. Therefore, that booster dose was actually his fourth dose.  While receiving the booster dose the reporter reported that when the vaccinator pulled out the syringe, he felt leakage as liquid rolled down his left arm. The reporter asked the vaccinator what the liquid was and he was told it was rubbing alcohol coming out.  The reporter stated at his age, he considers himself immunocompromised although he reported he has not been classified as being immunocompromised by his doctor.  No treatment medications were provided.   This case was linked to MOD-2022-455602, MOD-2022-455587 (Patient Link).   Reporter did not allow further contact
Age: 13.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".) in a 13-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".). On 11-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old patient received 1st dose of Moderna vaccine on accident "thought the 13 year old looked 18".) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drug details were reported. It was reported one unknown 13 year old patient received the 1st dose of Moderna vaccine on 11Dec2021 on accident thought the 13 year old looked 18. No side effects were reported by nurse.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received an expired Moderna vaccine booster dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received an expired Moderna vaccine booster dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041J21A, 026B21A and 002C21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and OMEPRAZOLE for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (received an expired Moderna vaccine booster dose). On 18-Jan-2022, EXPIRED PRODUCT ADMINISTERED (received an expired Moderna vaccine booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Moderna COVID-19 vaccine 1st dose on 02-MAY 2021, 2nd dose on 08-JUN-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna COVID-19 vaccine 1st dose on 02-MAY 2021, 2nd dose on 08-JUN-2021) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included ETANERCEPT (ENBREL) for an unknown indication.   On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 08-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna COVID-19 vaccine 1st dose on 02-MAY 2021, 2nd dose on 08-JUN-2021). On 08-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna COVID-19 vaccine 1st dose on 02-MAY 2021, 2nd dose on 08-JUN-2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that she took 3rd dose/ booster (0.25ml) 19-Jan-2022 at the same time with the flu shot and she about to receive another 0.25ml dose of the Moderna COVID-19 vaccine as the pharmacist considered the patient was an immunocompromised. No treatment information was provided.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Vomiting
Clinical narrative: experiencing a severe migraine headache; Vomiting; body aches; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (experiencing a severe migraine headache), VOMITING (Vomiting) and MYALGIA (body aches) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced MIGRAINE (experiencing a severe migraine headache), VOMITING (Vomiting) and MYALGIA (body aches). At the time of the report, MIGRAINE (experiencing a severe migraine headache), VOMITING (Vomiting) and MYALGIA (body aches) outcome was unknown.            Concomitant medications was not reported.  Treatment medications was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose, Antibody test, Inappropriate schedule of product administration
Clinical narrative: Booster instead of third dose in immunocompromised; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Booster instead of third dose in immunocompromised) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, the patient experienced ACCIDENTAL UNDERDOSE (Booster instead of third dose in immunocompromised) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 22-Aug-2021, ACCIDENTAL UNDERDOSE (Booster instead of third dose in immunocompromised) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Antibody test: negative (Negative) Negative- Patient did not have any antibody protection..         No concomitant medication were reported.  No treatment information were provided.  Her rheumatologist had suggested that she should proceed with receiving the fourth dose.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Protein S
Clinical narrative: little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore arm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised and Asthmatic. Concomitant products included BUDESONIDE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, HYDROCHLOROTHIAZIDE, MELOXICAM, PANTOPRAZOLE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), LOSARTAN POTASSIUM, AMLODIPINE BESILATE (AMLODIPINE BESYLATE), PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little sore arm). At the time of the report, PAIN IN EXTREMITY (little sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jul-2021, Protein S: 1993 (abnormal) abnormal. On 27-Oct-2021, Protein S: 1019 (abnormal) abnormal. On 17-Jan-2022, Protein S: 197 (abnormal) abnormal.         Patient was tested for S and N proteins (probably talking about antibodies against those proteins). Patient was tested on 27Jul2021, then on 27Oct2021 and finally on 17Jan2022. S protein levels were 1993, 1019 and 197 for the 1st, 2nd and 3rd test, respectively. In all N protein level was 0.  No treatment medication was reported.   This case was linked to MOD-2022-455735, MOD-2022-455738 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2022: Non-significant follow up
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Protein S
Clinical narrative: little sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (little sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic and Immunocompromised. Concomitant products included BUDESONIDE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, HYDROCHLOROTHIAZIDE, MELOXICAM, PANTOPRAZOLE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), LOSARTAN POTASSIUM, AMLODIPINE BESILATE (AMLODIPINE BESYLATE), PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little sore arm). At the time of the report, PAIN IN EXTREMITY (little sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jul-2021, Protein S: 1993 (abnormal) Abnormal. On 27-Oct-2021, Protein S: 1019 (abnormal) Abnormal. On 17-Jan-2022, Protein S: 197 (abnormal) Abnormal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was tested on 27-Jul-2021, then on 27-Oct-2021 and finally on 17-Jan-2022. In all N protein level was 0. No treatment was provided by the reporter.   This case was linked to MOD-2022-455714, MOD-2022-455738 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2022: Non significant follow up appended.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Migraine, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Had migraines), FATIGUE (tired), NAUSEA (nauseous), PYREXIA (fever) and CHILLS (chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A-1 and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported.In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Had migraines), FATIGUE (tired), NAUSEA (nauseous), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches). At the time of the report, MIGRAINE (Had migraines), FATIGUE (tired), NAUSEA (nauseous), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.    No concomitant medications reported by reporterNo treatment medications provided by the reporter. This case was linked to MOD-2022-455718, MOD-2022-455739 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Had migraines), FATIGUE (tired), NAUSEA (nauseous), PYREXIA (fever) and CHILLS (chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A-1 and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported.In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Had migraines), FATIGUE (tired), NAUSEA (nauseous), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches). At the time of the report, MIGRAINE (Had migraines), FATIGUE (tired), NAUSEA (nauseous), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.    No concomitant medications reported by reporterNo treatment medications provided by the reporter. This case was linked to MOD-2022-455718, MOD-2022-455739 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic and Immunocompromised. Concomitant products included BUDESONIDE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, HYDROCHLOROTHIAZIDE, MELOXICAM, PANTOPRAZOLE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), LOSARTAN POTASSIUM, AMLODIPINE BESILATE (AMLODIPINE BESYLATE), PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little sore arm). At the time of the report, PAIN IN EXTREMITY (little sore arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was provided.  patient complaint about Moderna Vaccine lack of effectiveness literally said she questioning the effectiveness of it. In the study patient was tested for S and N proteins (probably talking about antibodies against those proteins). Patient was tested on 27 Jul 2021, then on 27 Oct 2021 and finally on 17 Jan 2022. S protein levels were 1993, 1019 and 197 for the 1st, 2nd and 3rd test, respectively. In all N protein  level was 0. Patient expected to increase or at least maintain the number after booster, but it dropped abruptly. After the 3 doses had a little sore arm for 24 hours. Spoke with HCP to receive advice but HCP said that the numbers mean nothing and refused doing a blood test. Patient asked if it was possible to find out any issues the vaccine might have undergone using the lot number.   This case was linked to MOD-2022-455735, MOD-2022-455714 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2022: Non significant follow up.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Musculoskeletal stiffness, Nausea
Clinical narrative: back started getting very stiff.; tired after booster dose; nausea; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (back started getting very stiff.), FATIGUE (tired after booster dose), NAUSEA (nausea) and HEADACHE (bad headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A, 008C21A and 021B21A-1) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jan-2022, the patient experienced MUSCULOSKELETAL STIFFNESS (back started getting very stiff.), FATIGUE (tired after booster dose), NAUSEA (nausea) and HEADACHE (bad headache). At the time of the report, MUSCULOSKELETAL STIFFNESS (back started getting very stiff.), FATIGUE (tired after booster dose), NAUSEA (nausea) and HEADACHE (bad headache) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-455718, MOD-2022-455736 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: normal pain after getting the vaccines; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (normal pain after getting the vaccines) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 033C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE PAIN (normal pain after getting the vaccines). In April 2021, VACCINATION SITE PAIN (normal pain after getting the vaccines) had resolved.            No Concomitant Drug details were reported.  No Treatment information was provided.  Patient went to get the second dose was instructed by the pharmacist to start the series all over. And so, got a second dose and a third dose as a new primary series.   This case was linked to MOD-2022-455747 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: normal pain after getting the vaccines; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (normal pain after getting the vaccines) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN (normal pain after getting the vaccines). In 2021, PAIN (normal pain after getting the vaccines) had resolved.            No concomitant medication was reported.  Patient got initial Moderna dose in one city and then patient moved to different place and when they went to get the second dose was instructed by the pharmacist to start the series all over. And so,  got a second dose and a third dose as a new primary series. Patient had only normal pain lasted for a day or two.  No treatment information was provided.   This case was linked to MOD-2022-455742 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Fatigue, Malaise, Muscle strain
Clinical narrative: pulled muscles in abdomen; Had mild tempreture,around 99-100F; felt pretty rotten for 2 days; felt very run down/I just didn't want to do anything for a couple of days; pretty strong body aches; sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE STRAIN (pulled muscles in abdomen), BODY TEMPERATURE INCREASED (Had mild tempreture,around 99-100F), MALAISE (felt pretty rotten for 2 days), FATIGUE (felt very run down/I just didn't want to do anything for a couple of days) and MYALGIA (pretty strong body aches) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced BODY TEMPERATURE INCREASED (Had mild tempreture,around 99-100F) and VACCINATION SITE PAIN (sore arm at the injection site). 08-May-2021, the patient experienced MALAISE (felt pretty rotten for 2 days), FATIGUE (felt very run down/I just didn't want to do anything for a couple of days) and MYALGIA (pretty strong body aches). On an unknown date, the patient experienced MUSCLE STRAIN (pulled muscles in abdomen). On 09-May-2021, MALAISE (felt pretty rotten for 2 days) had resolved. At the time of the report, MUSCLE STRAIN (pulled muscles in abdomen), BODY TEMPERATURE INCREASED (Had mild tempreture,around 99-100F), FATIGUE (felt very run down/I just didn't want to do anything for a couple of days), MYALGIA (pretty strong body aches) and VACCINATION SITE PAIN (sore arm at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-May-2021, Body temperature: mild temperature of 99-100f (High) mild temperature of 99-100F.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-455486, MOD-2022-455756 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: pulled muscles in abdomen; Had mild tempreture,around 99-100F; felt pretty rotten for 2 days; felt very run down/I just didn't want to do anything for a couple of days; pretty strong body aches; sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE STRAIN (pulled muscles in abdomen), BODY TEMPERATURE INCREASED (Had mild tempreture,around 99-100F), MALAISE (felt pretty rotten for 2 days), FATIGUE (felt very run down/I just didn't want to do anything for a couple of days) and MYALGIA (pretty strong body aches) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced BODY TEMPERATURE INCREASED (Had mild tempreture,around 99-100F) and VACCINATION SITE PAIN (sore arm at the injection site). 08-May-2021, the patient experienced MALAISE (felt pretty rotten for 2 days), FATIGUE (felt very run down/I just didn't want to do anything for a couple of days) and MYALGIA (pretty strong body aches). On an unknown date, the patient experienced MUSCLE STRAIN (pulled muscles in abdomen). On 09-May-2021, MALAISE (felt pretty rotten for 2 days) had resolved. At the time of the report, MUSCLE STRAIN (pulled muscles in abdomen), BODY TEMPERATURE INCREASED (Had mild tempreture,around 99-100F), FATIGUE (felt very run down/I just didn't want to do anything for a couple of days), MYALGIA (pretty strong body aches) and VACCINATION SITE PAIN (sore arm at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-May-2021, Body temperature: mild temperature of 99-100f (High) mild temperature of 99-100F.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-455486, MOD-2022-455756 (Patient Link).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Joint stiffness
Clinical narrative: I'm dizzy at times; a mild headache/head a little swirly, & a mild headache; My right ankle is painful; My right ankle is incredibly stiff, I have to loosen it up to get it going; achiness; kind of run down/Super fatigued; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (My right ankle is incredibly stiff, I have to loosen it up to get it going), DIZZINESS (I'm dizzy at times), MYALGIA (achiness), FATIGUE (kind of run down/Super fatigued) and HEADACHE (a mild headache/head a little swirly, & a mild headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001JN2A, 027C21A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2022, the patient experienced MYALGIA (achiness) and FATIGUE (kind of run down/Super fatigued). On 16-Jan-2022, the patient experienced JOINT STIFFNESS (My right ankle is incredibly stiff, I have to loosen it up to get it going) and ARTHRALGIA (My right ankle is painful). On 19-Jan-2022, the patient experienced DIZZINESS (I'm dizzy at times) and HEADACHE (a mild headache/head a little swirly, & a mild headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of 400mg.. At the time of the report, JOINT STIFFNESS (My right ankle is incredibly stiff, I have to loosen it up to get it going), DIZZINESS (I'm dizzy at times), MYALGIA (achiness), FATIGUE (kind of run down/Super fatigued), HEADACHE (a mild headache/head a little swirly, & a mild headache) and ARTHRALGIA (My right ankle is painful) outcome was unknown.            Concomitant medication was not provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: I'm dizzy at times; a mild headache/head a little swirly, & a mild headache; My right ankle is painful; My right ankle is incredibly stiff, I have to loosen it up to get it going; achiness; kind of run down/Super fatigued; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (My right ankle is incredibly stiff, I have to loosen it up to get it going), DIZZINESS (I'm dizzy at times), MYALGIA (achiness), FATIGUE (kind of run down/Super fatigued) and HEADACHE (a mild headache/head a little swirly, & a mild headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001JN2A, 027C21A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2022, the patient experienced MYALGIA (achiness) and FATIGUE (kind of run down/Super fatigued). On 16-Jan-2022, the patient experienced JOINT STIFFNESS (My right ankle is incredibly stiff, I have to loosen it up to get it going) and ARTHRALGIA (My right ankle is painful). On 19-Jan-2022, the patient experienced DIZZINESS (I'm dizzy at times) and HEADACHE (a mild headache/head a little swirly, & a mild headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of 400mg.. At the time of the report, JOINT STIFFNESS (My right ankle is incredibly stiff, I have to loosen it up to get it going), DIZZINESS (I'm dizzy at times), MYALGIA (achiness), FATIGUE (kind of run down/Super fatigued), HEADACHE (a mild headache/head a little swirly, & a mild headache) and ARTHRALGIA (My right ankle is painful) outcome was unknown.            Concomitant medication was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, Inappropriate schedule of product administration
Clinical narrative: First dose on 25 Jan 2021 and second dose on 18 Jan 2022; Booster dose given as a 2nd primary dose, instead of a full dose received it as a booster dose of 0.25 mL; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 25 Jan 2021 and second dose on 18 Jan 2022) and ACCIDENTAL UNDERDOSE (Booster dose given as a 2nd primary dose, instead of a full dose received it as a booster dose of 0.25 mL) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 18-Jan-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 25 Jan 2021 and second dose on 18 Jan 2022) and ACCIDENTAL UNDERDOSE (Booster dose given as a 2nd primary dose, instead of a full dose received it as a booster dose of 0.25 mL). On 18-Jan-2022, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 25 Jan 2021 and second dose on 18 Jan 2022) and ACCIDENTAL UNDERDOSE (Booster dose given as a 2nd primary dose, instead of a full dose received it as a booster dose of 0.25 mL) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2022-455746 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013m208 and 0276208) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown.            Patient DOB was 1949. No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2022-455763 (Patient Link).